Human CX3CR1 (extracellular) Blocking Peptide (#BLP-CR059) is the original antigen used for immunization during Anti-Human CX3CR1 (extracellular) Antibody (#ACR-059) generation. The blocking peptide binds and ‘blocks’ Anti-Human CX3CR1 (extracellular) primary antibody, this makes it a good negative reagent control to help confirm antibody specificity in western blot and immunohistochemistry applications. This control is also often called a pre-adsorption control.
- Western blot analysis of human NK-92MI natural killer cells (lanes 1 and 3) and human THP-1 acute monocytic leukemia (lanes 2 and 4) cell lysates:
- (C)ESVTENFEYDDLAE, corresponding to amino acid residues 6-19 of human CX3CR1 (Accession P49238).